Company
Forest Road Acquisition Corp.
Headquarters: New York, NY, United States
Employees: 10
CEO: Mr. Rostislav Raykov
Market Cap
C$217.8 Million
CAD as of July 1, 2024
US$158.5 Million
Forest Road Acquisition Corp. Categories
United States Financials Shell CompaniesUnited States Financials United States Shell Companies
Top Competitors by Market Capitalization
Industry: Shell Companies
Sector:
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $887.16 B |
| JPMorgan | $599.29 B |
| Visa | $550.38 B |
| Mastercard | $416.63 B |
| Bank of America | $316.02 B |
Detailed Description
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate that has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Forest Road Acquisition Corp. has the following listings and related stock indices.
Stock: NYSE: FRX wb_incandescent